Registers 10.1M Shares for Resale, Signaling Significant Potential Dilution
AIDX sits 36% above its 52-week low of $1.51 on light trading volume (0.3× avg).
Summary
20/20 Biolabs filed an S-1 to register over 10 million shares for resale and conversion, representing nearly 100% potential dilution, with minimal proceeds to the company.
Key Events · Financing and Capital Events · AIDX
-
Registration of 10.1 Million Shares
The company registered 10,105,000 shares of common stock for resale by selling stockholders and for conversion of existing preferred stock and convertible notes.
-
Significant Potential Dilution
These registered shares represent approximately 96.76% of the currently outstanding common stock, indicating a substantial potential for dilution if all shares are issued.
-
Minimal Proceeds to Company
The company will not receive proceeds from most of these sales, except for up to $500,000 from the exercise of warrants.
-
Follows Recent Direct Listing and Capital Raises
This is a subsequent registration statement, fulfilling a requirement from prior agreements following the company's direct listing on Nasdaq on February 19, 2026, and recent capital raises.
Analysis · AIDX · Industrial Applications And Services
This S-1 filing registers 10,105,000 shares of common stock for resale by selling stockholders and for conversion of existing preferred stock and convertible notes. This represents a potential dilution of approximately 96.76% of the current outstanding common stock, creating a substantial overhang on the stock. The company will receive minimal proceeds from these transactions, primarily up to $500,000 from warrant exercises. This is a subsequent registration statement following the company's direct listing on Nasdaq on February 19, 2026, and recent capital raises. The filing reiterates a "going concern" warning, highlighting ongoing capital needs and the significant dilutive impact of its financing structure.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 42% of the 419 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AIDX was trading at $2.05 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $11M. The 52-week trading range was $1.51 to $50.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.